Response to Letter to the Editor for "Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia" [0.03%]
/response to 有关“低剂量infigratinib治疗软骨发育不全疗效良好”的来信
Laurence Legeai-Mallet,Bhavik Shah
Laurence Legeai-Mallet
Infigratinib is a weak inhibitor of the FGFR3-N540K mutant associated with hypochondroplasia [0.03%]
インフィグリブマ是一种与低矮侏儒症相关的FGFR3-N540K突变的弱抑制剂
Vlad-Constantin Ursachi,Zuzana Feketova,Aleksandra Anna Czyrek et al.
Vlad-Constantin Ursachi et al.
Decreased Nonvertebral Fracture Incidence with Zoledronate Use For >3 Years: Post Hoc Analysis of an RCT [0.03%]
一项随机试验的事后分析：唑来膦酸长期（大于3年）使用可减少非椎体骨折发生率
Ian R Reid,Anne M Horne,Borislav Mihov et al.
Ian R Reid et al.
The anti-fracture efficacy of most osteoporosis drugs is assessed in trials of up to three years duration. However, treatment of osteoporosis is required long-term, so it is important to know whether effectiveness of treatment changes over ...
Response to Letter to the Editor Regarding "The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABER project" [0.03%]
关于“FNIH-ASBMR-SABER项目：骨质疏松症临床试验中髋关节总骨密度在12、18和24个月的变化与骨折风险降低的关系”的信件答复
Tatiane Vilaca,Marian Schini,Li-Yung Lui et al.
Tatiane Vilaca et al.
Center for Promoting Treatment of Intractable Diseases, ISEIKAI International General Hospital [0.03%]
难病治疗促进中心(ISEIKAI国际综合医院)
Keiichi Ozono
Keiichi Ozono
A novel model to study the impact of gender-affirming therapy on bone in young male mice [0.03%]
一种研究性别肯定疗法对年轻雄性小鼠骨骼影响的新模型
Lieve Verlinden,Sandra Calvo Blanco,Toke Liekens et al.
Lieve Verlinden et al.
Transgender individuals are increasingly seeking gender-affirming therapy. For children and adolescents, this typically involves puberty suppression followed by hormone treatment. However, potential long-term adverse effects on the growing ...
QCT-based geometric, densitometric and biomechanical properties of the ageing human thoracolumbar spine [0.03%]
基于QCT的成人腰椎 aging的人体胸腰段脊柱的几何学、密度和生物力学特性
J Xu,H Hemmatazad,M Indermaur et al.
J Xu et al.
Vertebral fractures represent a growing health issue in our aging societies. We performed a large-scale quantitative assessment of the geometric, densitometric, and biomechanical characteristics of the aging thoracolumbar spine using quanti...
Letter to the Editor Regarding "The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 months and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project" [0.03%]
关于“FNIH-ASBMR-SABRE项目中骨质疏松症临床试验中，治疗相关总髋部BMD变化与骨折风险降低的关系”的来信
Edwin Mora Garzón
Edwin Mora Garzón